IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacy. - Castelli S; Wilson WV; Uslu U; Finck AV; Rommel PC; Assenmacher CA; Atoche SJ; Siurala M; Aznar MA; Young RM; June CH (Immunity, 2026)